<center id="eiaca"></center>
  • <samp id="eiaca"><label id="eiaca"></label></samp>
    <samp id="eiaca"><s id="eiaca"></s></samp>
  • 訂購/客服:400-623-8666 | 021-50706066
    通過類別精選:
    手性藥用中間體
    手性催化劑,配體和試劑
    手性助劑
    手性砌塊
    拆分試劑

    COA查詢:

    例如:
    批號:C10268951
    貨號:A800295-25g

    在貨品標簽上如何找到貨號和批號?
    點擊這里查看標簽示例
    產品編號 CAS號 項目名稱規格 分子式 加入購物車
    B804593 85116-37-6 (-)-B-氯化二異松香芹硼烷, 60% in Heptane, ca. 1.7 mol/L, MkSeal
    (-)-B-Chlorodiisopinocampheylborane, 60% in Heptane, ca. 1.7 mol/L, MkSeal
    C20H34BCl
    R859587 1429939-35-4 (+)-1,13-雙[二(3,5-二甲基苯基)膦]-(5AR,8AR,14aR)-5a,6,7,8,8a,9-六氫-5-H-[1]苯并吡喃, 98%purity,99%e.e.
    1,1'-[(5aR,8aR,14aR)-5a,6,7,8,8a,9-Hexahydro-5H-[1]Benzopyrano[3,2-d]Xanthene-1,13-Diyl]Bis[1,1-di(3,5-Dimethylphenylphosphine, 98%purity,99%e.e.
    C52H54O2P2
    B906137 99135-95-2 (+)-N-芐基-(3R,4R)-雙(二苯基膦)吡咯烷, 98%
    1-Benzyl-3,4-(R,R)-bis(diphenylphosphino)pyrrolidine, 98%
    C35H33NP2
    B804592 112246-73-8 (+)二異松蒎基氯硼烷, 60% in Heptane,ca. 1.7mol/L
    (+)-B-Chlorodiisopinocampheylborane, 60% in Heptane,ca. 1.7mol/L
    C20H34BCl
    S859594 1439556-82-7 (-)-1,13-Bis(diphenyl)phosphino-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 98%purity,99%e.e.
    (S,S,S)-(-)-Ph-SKP, 98%purity,99%e.e.
    C44H38O2P2
    S859586 1429939-31-0 (-)-1,13-Bis[di(3,5-dimethylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 98%purity,99%e.e.
    (S,S,S)-(-)-Xyl-SKP, 98%purity,99%e.e.
    C52H54O2P2
    S859613 1548897-80-8 (-)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 98%purity,99%e.e.
    (S,S,S)-(-)-Tol-SKP, 98%purity,99%e.e.
    C48H46O2P2
    S906113 1787246-78-9 (-)-茚胺醇2,6-二乙基苯肼三氮唑, 97%
    (5aS,10bR)-2-(2,6-Diethylphenyl)-4,5a,6,10b-tetrahydro-2H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-11-ium tetrafluoroborate, 97%
    C22H24BF4N3O
    R854260 1297613-73-0 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    C37H27O4P
    R854262 1297613-74-1 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    C37H27O4P
    R854269 1372719-93-1 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    C45H31O4P
    R854255 1297613-72-9 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    C29H23O4P
    R853903 930784-57-9 (11aR)-10,11,12,13-Tetrahydro-N,N,3,7-tetramethyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%
    (11aR)-10,11,12,13-Tetrahydro-N,N,3,7-tetramethyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%
    C21H24NO2P
    R853904 500997-69-3 (11aR)-10,11,12,13-Tetrahydro-N,N-bis[(1R)-1-phenylethyl]-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%,≥99% e.e.
    (11aR)-10,11,12,13-Tetrahydro-N,N-bis[(1R)-1-phenylethyl]-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%,≥99% e.e.
    C33H32NO2P
    R854400 (11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
    (11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
    C37H39O4P
    R854398 (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,≥99%e.e.
    (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,≥99%e.e.
    C49H31O4P
    R854276 1801196-27-9 (11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    (11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    C35H35O4P
    R854406 (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
    (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
    C29H19Cl4O4P
    R854259 1297613-75-2 (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
    C33H31O4P
    R854402 (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
    (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
    C31H21F6O4P
    首頁|網站使用條款|隱私政策|關于我們|網站地圖
    Copyright ? 2014 Macklin Inc. - All rights reserved. 滬ICP備14004368號

    本網站銷售的所有產品僅用于工業應用或者科學研究等非醫療目的,不可用于人類或動物的臨床診斷或治療,非藥用,非食用。


    滬公網安備 31011502007856號

    危險品化學品經營許可證(帶存儲)

       
    請填寫購買數量! 您已收藏過此產品! 成功從購物車刪除! 成功清楚購物車!
    英语老师叫我帮她脱丝袜视频
    <center id="eiaca"></center>
  • <samp id="eiaca"><label id="eiaca"></label></samp>
    <samp id="eiaca"><s id="eiaca"></s></samp>